Actinogen Medical Limited operates as a biotechnology company. The Company focuses on the treatment of alzheimer's disease and mild cognitive impairment. Actinogen Medical develops a novel drug to treat the condition and other age-related neurodegenerative diseases.
Activity
Last price
$0.094
Change
0.002 (2.17%)
Bid/Ask
$0.090 - $0.094
Volume
560,256.00
Volume traded/total %
0.031%
Volume avg (4w)
1.02M
Open
$0.092
Day range
$0.090 - $0.094
Previous Close
$0.092
Last Trade
20 Jan, 5:10 am UTC
Size
Market Cap
$166.18M
Market Rank
829
Industry Rank
22
Fundamentals
Shares Issued
1.81B
Earnings Per Share (EPS)
$-0.006
Dividends Per Share (DPS)
-
P/E Ratio
-
Similar to
Related Stories
Grafa
Actinogen Medical (ASX:ACW) announces quarterly results
Grafa
Actinogen Medical (ASX:ACW) FDA approves Alzheimer's trial
Grafa
Actinogen Medical (ASX:ACW) announced the completion of a recent capital raise.
Grafa
ACW (ASX:ACW) reveals positive data for Alzheimer’s
Grafa
The biggest movers of the featherweight companies today
Skip for now >
FIRST THINGS FIRST
See all your stocks, crypto and forex on your personalised watchlist
Grafa reacts to your watchlist, so you get data, news and insights about the assets you care about.